2020 ASCO Virtual Direct™ Highlights

 

GU
08:56

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Advanced Prostate Cancer: Is Relugolix Better Tolerated Than Leuprolide Acetate?

FEATURING Brad Somer
  • 7 views
  • September 27, 2020
13:12

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on PSMA in Prostate Cancer: How Useful Is 18F-DCFPyL PET/CT for Recurrent Disease Detection? Are PSA Response Rates Higher With 177Lu-PSMA-617 vs. Cabazitaxel?

FEATURING Brad Somer
  • 3 views
  • September 27, 2020
11:01

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Updates on CRPC: Apalutamide vs. Enzalutamide vs. Darolutamide - What Are the MFS/OS Results for nmCRPC? How Does FDA Approved Rucaparib Work in Patients With BRCA Mutated Disease?

FEATURING Brad Somer
  • 6 views
  • September 27, 2020
11:09

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Advanced Bladder Cancer: Can We Consider Avelumab 1L Maintenance a New SoC?

FEATURING Manojkumar Bupathi
  • 48 views
  • August 13, 2020
12:28

2020 ASCO Virtual Direct™ Highlights

2020 ASCO mRCC Highlights: Does the Updated KEYNOTE-426 Analysis Support Pembrolizumab + Axitinib Superiority Over Sunitinib? Does Tumor Shrinkage Correlate With OS?

FEATURING Manojkumar Bupathi
  • 48 views
  • August 6, 2020
08:36

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Bladder Cancer: Does Adjuvant Atezolizumab Improve DFS in Patients With High-risk MIUC?

FEATURING Manojkumar Bupathi
  • 70 views
  • August 4, 2020